Michael O’Dwyer

1 month ago | nature.com | Philippe Moreau |Katja Weisel |Hartmut Goldschmidt |Saad Usmani |Robert Orlowski |Nizar Bahlis | +7 more

AbstractIn the MAIA study, daratumumab plus lenalidomide and dexamethasone (D-Rd) improved progression-free survival (PFS) and overall survival (OS) versus lenalidomide and dexamethasone (Rd) alone in transplant-ineligible patients with newly diagnosed multiple myeloma (NDMM). We report updated efficacy and safety from MAIA (median follow-up, 64.5 months), including a subgroup analysis by patient age (<70, ≥70 to <75, ≥75, and ≥80 years).

Jan 20, 2025 | bikepacking.com | Matt Smith |Logan Watts |Michael O’Dwyer |Lucas Winzenburg

In this edition of Weekend Snapshot, we join a few folks from our global bikepacking community on their recent outings. From Mexico’s lush mountains to a frozen lake in Sweden, today’s scenes are a reminder to appreciate the beauty in all seasons. See them and share a photo from one of your rides here…No matter the weather, people from across our worldwide community are reliably out pedaling trails during their time off, and last weekend was no exception.

Nov 22, 2024 | ft.com | Jim Pickard |Michael O’Dwyer |Joshua Oliver

British companies face a stealth tax rise of £900mn next year and up to £2.7bn in 2026 through higher business rates, despite Labour’s...

Nov 22, 2024 | ft.com | Valentina Romei |Michael O’Dwyer |Sam Fleming

UK business activity shrank for the first time in more than a year, according to a closely watched survey, as the private sector warned...

Nov 21, 2024 | ft.com | Michael O’Dwyer

Sitting at the back of the Great Hall in the City of London’s historic Guildhall, I crane my neck to see Alastair King place his hat on...